Stromal targeted therapy in bone metastatic prostate cancer: promise delivered

Por Sartor, Oliver, Goeckeler, William, Bruland, Oyvind
Publicado em 2011

Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009

Por Berner, Kjetil, Johannesen, Tom Børge, Bruland, Øyvind S.
Publicado no Sarcoma (2015)

Seasonal variations of cancer incidence and prognosis

Por Moan, Johan, Lagunova, Zoya, Bruland, Øyvind, Juzeniene, Asta
Publicado em 2010

Cured of Primary Bone Cancer, But at What Cost: A Qualitative Study of Functional Impairment and Lost Opportunities

Por Fauske, Lena, Bruland, Oyvind S., Grov, Ellen Karine, Bondevik, Hilde
Publicado no Sarcoma (2015)

Breed-specific incidence rates of canine primary bone tumors — A population based survey of dogs in Norway

Por Anfinsen, Kristin P., Grotmol, Tom, Bruland, Oyvind S., Jonasdottir, Thora J.
Publicado em 2011

Clinical implications of repeated drug monitoring of imatinib in patients with metastatic gastrointestinal stromal tumour

Por Hompland, Ivar, Bruland, Øyvind Sverre, Ubhayasekhera, Kumari, Bergquist, Jonas, Boye, Kjetil
Publicado no Clin Sarcoma Res (2016)

Experimental α-particle radioimmunotherapy of breast cancer using (227)Th-labeled p-benzyl-DOTA-trastuzumab

Por Abbas, Nasir, Heyerdahl, Helen, Bruland, Øyvind S, Borrebæk, Jørgen, Nesland, Jahn, Dahle, Jostein
Publicado em 2011

Radiotherapy or surgery for spine metastases?: A population-based study of 903 patients in the south-eastern region of Norway

Por Zaikova, Olga, Fosså, Sophie D, Bruland, Øyvind S, Giercksky, Karl-Erik, Sandstad, Berit, Skjeldal, Sigmund
Publicado em 2011

Radiotherapy for spinal metastases from breast cancer with emphasis on local disease control and pain response using repeated MRI

Por Switlyk, Marta D., Bruland, Øyvind S., Skjeldal, Sigmund, Hald, John K., Seierstad, Therese, Zaikova, Olga
Publicado no J Bone Oncol (2014)

Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT

Por Revheim, Mona-Elisabeth, Røe, Kathrine, Bruland, Øyvind Sverre, Bach-Gansmo, Tore, Skretting, Arne, Seierstad, Therese
Publicado em 2010

Prognostic Factors and Treatment Results of High-Grade Osteosarcoma in Norway: A Scope Beyond the “Classical” Patient

Por Berner, Kjetil, Hall, Kirsten Sundby, Monge, Odd R., Weedon-Fekjær, Harald, Zaikova, Olga, Bruland, Øyvind S.
Publicado no Sarcoma (2015)

Metastatic mesenteric dedifferentiated leiomyosarcoma: a case report and a review of literature

Por Varghese, Mercy, Bruland, Oyvind, Wiedswang, Anne Marit, Lobmaier, Ingvild, Røsok, Bård, Benjamin, Robert S., Hall, Kirsten Sundby
Publicado no Clin Sarcoma Res (2016)

Multimodal functional imaging for early response assessment in GIST patients treated with imatinib

Por Revheim, Mona-Elisabeth, Hole, Knut Håkon, Bruland, Øyvind Sverre, Reitan, Edmund, Bjerkehagen, Bodil, Julsrud, Lars, Seierstad, Therese
Publicado em 2014

Genome Analysis of Osteosarcoma Progression Samples Identifies FGFR1 Overexpression as a Potential Treatment Target and CHM as a Candidate Tumor Suppressor Gene

Por Barøy, Tale, Chilamakuri, Chandra S. R., Lorenz, Susanne, Sun, Jinchang, Bruland, Øyvind S., Myklebost, Ola, Meza-Zepeda, Leonardo A.
Publicado no PLoS One (2016)

Evaluation of CD146 as Target for Radioimmunotherapy against Osteosarcoma

Por Westrøm, Sara, Bønsdorff, Tina B., Abbas, Nasir, Bruland, Øyvind S., Jonasdottir, Thora J., Mælandsmo, Gunhild M., Larsen, Roy H.
Publicado no PLoS One (2016)

Intermittent and continuous imatinib in a human GIST xenograft model carrying KIT exon 17 resistance mutation D816H

Por Revheim, Mona-Elisabeth, Kristian, Alexandr, Malinen, Eirik, Bruland, Øyvind Sverre, Berner, Jeanne-Marie, Holm, Ruth, Joensuu, Heikki, Seierstad, Therese
Publicado em 2013

The Clinical Impact of Mean Vessel Size and Solidity in Breast Carcinoma Patients

Por Mikalsen, Lars Tore Gyland, Dhakal, Hari Prasad, Bruland, Øyvind S., Naume, Bjørn, Borgen, Elin, Nesland, Jahn M., Olsen, Dag Rune
Publicado em 2013

Time-trends on incidence and survival in a nationwide and unselected cohort of patients with skeletal osteosarcoma

Por Berner, Kjetil, Johannesen, Tom B⊘rge, Berner, Aasmund, Haugland, Hans Kristian, Bjerkehagen, Bodil, B⊘hler, Per J., Bruland, Øyvind S.
Publicado no Acta Oncol (2015)

(177)Lu-DOTA-HH1, a Novel Anti-CD37 Radio-Immunoconjugate: A Study of Toxicity in Nude Mice

Por Repetto-Llamazares, Ada H. V., Larsen, Roy H., Giusti, Anna Maria, Riccardi, Elena, Bruland, Øyvind S., Selbo, Pål Kristian, Dahle, Jostein
Publicado em 2014

Synovial sarcoma. Evaluation of Prognosis with Emphasis on the Study of DNA Ploidy and Proliferation (PCNA and Ki-67) Markers

Por M. Lopes, José, Hannisdal, Einar, Bjerkehagen, Bodil, Bruland, Øyvind S., Danielsen, Håvard E., Pettersend, Erik O., Sobrinho-Simões, Manuel, Nesland, Jahn M.
Publicado no Anal Cell Pathol (1998)